These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 36513915)
1. Opioid withdrawal symptoms after neurolytic splanchnic nerve block in cancer patients. Yanaizumi R; Nagamine Y; Harada S; Kuramochi T; Ota S; Goto T Support Care Cancer; 2022 Dec; 31(1):25. PubMed ID: 36513915 [TBL] [Abstract][Full Text] [Related]
2. Long-Term Analgesic Efficacy of Neurolytic Splanchnic Nerve Block via the Transintervertebral Disc Approach to Retrocrural Space: A Multicenter Retrospective Study. Yanaizumi R; Nagamine Y; Harada S; Kuramochi T; Ota S; Abe Y; Nakagawa M; Kamijima K; Hayashi M; Tazawa T; Ogawa K; Goto T Pain Ther; 2023 Jun; 12(3):825-840. PubMed ID: 37052814 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of Neurolytic Splanchnic Nerve Block via Transintervertebral Disc Approach to Retrocrural Space: A Multicenter Retrospective Study. Yanaizumi R; Nagamine Y; Harada S; Kuramochi T; Ota S; Abe Y; Nakagawa M; Kamijima K; Hayashi M; Tazawa T; Ogawa K; Goto T Pain Ther; 2022 Dec; 11(4):1359-1372. PubMed ID: 36169799 [TBL] [Abstract][Full Text] [Related]
4. Low pain intensity after opioid withdrawal as a first step of a comprehensive pain rehabilitation program predicts long-term nonuse of opioids in chronic noncancer pain. Krumova EK; Bennemann P; Kindler D; Schwarzer A; Zenz M; Maier C Clin J Pain; 2013 Sep; 29(9):760-9. PubMed ID: 23567163 [TBL] [Abstract][Full Text] [Related]
5. Opioid Tapering in Fibromyalgia Patients: Experience from an Interdisciplinary Pain Rehabilitation Program. Cunningham JL; Evans MM; King SM; Gehin JM; Loukianova LL Pain Med; 2016 Sep; 17(9):1676-85. PubMed ID: 26755658 [TBL] [Abstract][Full Text] [Related]
6. Intensity of Withdrawal Symptoms During Opioid Taper in Patients with Chronic Pain-Individualized or Fixed Starting Dosage? Bienek N; Maier C; Kaisler M; Michel-Lauter B; Schwarzer A; Meyer-Frießem CH Pain Med; 2019 Dec; 20(12):2438-2449. PubMed ID: 30806672 [TBL] [Abstract][Full Text] [Related]
7. [Neurolytic block of the celiac plexus and splanchnic nerves with computed tomography. The experience in 150 cases and an optimization of the technic]. Marra V; Debernardi F; Frigerio A; Menna S; Musso L; Di Virgilio MR Radiol Med; 1999 Sep; 98(3):183-8. PubMed ID: 10575450 [TBL] [Abstract][Full Text] [Related]
8. Neurolytic Splanchnic Nerve Block and Pain Relief, Survival, and Quality of Life in Unresectable Pancreatic Cancer: A Randomized Controlled Trial. Dong D; Zhao M; Zhang J; Huang M; Wang Y; Qi L; Wan CF; Yu X; Song T Anesthesiology; 2021 Oct; 135(4):686-698. PubMed ID: 34398950 [TBL] [Abstract][Full Text] [Related]
9. Opioid withdrawal presenting only nausea during tapering of oxycodone after celiac plexus block: a case report. Sakamoto A; Takayama H; Mamiya K; Koizumi T Ann Palliat Med; 2016 Jan; 5(1):67-70. PubMed ID: 26841817 [TBL] [Abstract][Full Text] [Related]
10. Comparison of rates of opioid withdrawal symptoms and reversal of opioid toxicity in patients treated with two naloxone dosing regimens: a retrospective cohort study. Purssell R; Godwin J; Moe J; Buxton J; Crabtree A; Kestler A; DeWitt C; Scheuermeyer F; Erdelyi S; Balshaw R; Rowe A; Cochrane CK; Ng B; Jiang A; Risi A; Ho V; Brubacher JR Clin Toxicol (Phila); 2021 Jan; 59(1):38-46. PubMed ID: 32401548 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of splanchnic nerve neurolysis in the management of upper abdominal cancer pain: A systematic review and meta-analysis. Goyal S; Kumar A; Goyal D; Attar P; Bhandari B; Purohit G; Mahiswar AP; Gupta S Indian J Anaesth; 2023 Dec; 67(12):1036-1050. PubMed ID: 38343676 [TBL] [Abstract][Full Text] [Related]
12. Assessment of outcomes following high-dose opioid tapering in a Veterans Healthcare System. Hundley L; Spradley S; Donelenko S J Opioid Manag; 2018; 14(2):89-101. PubMed ID: 29733095 [TBL] [Abstract][Full Text] [Related]
13. Escalation of Opioid Withdrawal Frequency and Subsequent AMA Rates in Hospitalized Patients From 2017 to 2020. Horton T; Subedi K; Sharma RA; Wilson B; Gbadebo BM; Jurkovitz C J Addict Med; 2022 Nov-Dec 01; 16(6):725-729. PubMed ID: 35675152 [TBL] [Abstract][Full Text] [Related]
14. Effectiveness of non-opioid interventions to reduce opioid withdrawal symptoms in patients with chronic pain: a systematic review. Langejan AI; de Kleijn L; Rijkels-Otters HJBM; Chudy SFJ; Chiarotto A; Koes BW Fam Pract; 2022 Mar; 39(2):295-300. PubMed ID: 34849764 [TBL] [Abstract][Full Text] [Related]
15. Comparison between radiofrequency ablation and chemical neurolysis of thoracic splanchnic nerves for the management of abdominal cancer pain, randomized trial. Amr SA; Reyad RM; Othman AH; Mohamad MF; Mostafa MM; Alieldin NH; Hamed FA Eur J Pain; 2018 Nov; 22(10):1782-1790. PubMed ID: 29975804 [TBL] [Abstract][Full Text] [Related]
16. How Do We Taper and Discontinue Opioids in Cancer Patients? Considerations from the Activities of a Palliative Care Team at a University Hospital. Kihara A; Shimada K; Tsuneto S Palliat Med Rep; 2021; 2(1):255-259. PubMed ID: 34927150 [No Abstract] [Full Text] [Related]
17. Low Volume Neurolytic Retrocrural Celiac Plexus Block for Visceral Cancer Pain: Retrospective Review of 507 Patients with Severe Malignancy Related Pain Due to Primary Abdominal Cancer or Metastatic Disease. Rahman A; Rahman R; Macrinici G; Li S Pain Physician; 2018 Sep; 21(5):497-504. PubMed ID: 30282394 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of coeliac plexus and splanchnic nerve blockades in body and tail located pancreatic cancer pain. Süleyman Ozyalçin N; Talu GK; Camlica H; Erdine S Eur J Pain; 2004 Dec; 8(6):539-45. PubMed ID: 15531222 [TBL] [Abstract][Full Text] [Related]
19. [Computerized tomography-guided neurolytic block of the splanchnic nerve]. Cariati M; Henriquet F; Fiorentini F; De Martini G; Pretolesi F; Roy MT; Martinoli C Radiol Med; 1997 Jun; 93(6):739-42. PubMed ID: 9411523 [TBL] [Abstract][Full Text] [Related]